DTIL
Precision BioSciences Inc
6.30$
+1.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -46.4% | +149.8% | +183.8% | -98.8% | +10.8% | -95.5% | -37.9% | -27.8% | +263,007.7% | -68.3% | -100.0% | – | |
| – | -23.6% | -8.3% | -3.2% | -26.8% | -25.1% | – | – | -3.2% | +0.6% | – | – | – | |
| – | -36.5% | +149.8% | +183.8% | -98.8% | +10.8% | -95.5% | -37.9% | -27.8% | +263,007.7% | -68.3% | – | – | |
| – | -9.8% | -0.3% | +29.1% | -24.0% | +21.6% | -14.6% | -6.0% | +4.6% | +8.3% | -9.4% | -5.5% | – | |
| – | -11.4% | -1.3% | +1.2% | +2.8% | +9.2% | -10.7% | +6.7% | -19.7% | -1.3% | -5.9% | -0.5% | – | |
| – | -6.5% | -0.7% | +18.3% | -15.1% | +16.6% | -13.1% | -1.1% | -5.5% | +4.9% | -8.2% | -3.8% | – | |
| – | – | – | – | -188.1% | – | – | – | – | – | -172.6% | – | – | |
| – | +0.5% | -0.9% | -2.4% | -54.3% | +53.1% | -9.7% | +1.1% | +1.1% | -3.9% | -10.6% | -3.5% | – | |
| – | – | – | +281.3% | -150.2% | – | – | – | – | – | -195.8% | – | – | |
| – | – | -51.5% | -199.9% | – | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | +281.3% | -150.2% | – | – | – | – | – | -191.6% | – | – | |
| – | – | – | +227.6% | -143.7% | – | – | – | – | – | -186.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.